Literature DB >> 17110701

Glomerular filtration rate: screening cannot be recommended on the basis of current knowledge.

Catherine M Clase.   

Abstract

Mesh:

Year:  2006        PMID: 17110701      PMCID: PMC1647391          DOI: 10.1136/bmj.39030.594259.BE

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  10 in total

1.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

Review 2.  Low protein diets for chronic kidney disease in non diabetic adults.

Authors:  D Fouque; M Laville; J P Boissel
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

3.  Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey.

Authors:  Stein I Hallan; Ketil Dahl; Cecilia M Oien; Diana C Grootendorst; Arne Aasberg; Jostein Holmen; Friedo W Dekker
Journal:  BMJ       Date:  2006-10-24

4.  Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

Authors:  Andrew S Levey; Kai-Uwe Eckardt; Yusuke Tsukamoto; Adeera Levin; Josef Coresh; Jerome Rossert; Dick De Zeeuw; Thomas H Hostetter; Norbert Lameire; Garabed Eknoyan
Journal:  Kidney Int       Date:  2005-06       Impact factor: 10.612

5.  Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data.

Authors:  T H Jafar; C H Schmid; M Landa; I Giatras; R Toto; G Remuzzi; G Maschio; B M Brenner; A Kamper; P Zucchelli; G Becker; A Himmelmann; K Bannister; P Landais; S Shahinfar; P E de Jong; D de Zeeuw; J Lau; A S Levey
Journal:  Ann Intern Med       Date:  2001-07-17       Impact factor: 25.391

6.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

Authors:  B M Brenner; M E Cooper; D de Zeeuw; W F Keane; W E Mitch; H H Parving; G Remuzzi; S M Snapinn; Z Zhang; S Shahinfar
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

7.  Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors:  Mahboob Rahman; Sara Pressel; Barry R Davis; Chuke Nwachuku; Jackson T Wright; Paul K Whelton; Joshua Barzilay; Vecihi Batuman; John H Eckfeldt; Michael Farber; Mario Henriquez; Nelson Kopyt; Gail T Louis; Mohammad Saklayen; Carol Stanford; Candace Walworth; Harry Ward; Thomas Wiegmann
Journal:  Arch Intern Med       Date:  2005-04-25

8.  Unreferred chronic kidney disease: a longitudinal study.

Authors:  Robert John; Michelle Webb; Alan Young; Paul E Stevens
Journal:  Am J Kidney Dis       Date:  2004-05       Impact factor: 8.860

9.  National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors:  Andrew S Levey; Josef Coresh; Ethan Balk; Annamaria T Kausz; Adeera Levin; Michael W Steffes; Ronald J Hogg; Ronald D Perrone; Joseph Lau; Garabed Eknoyan
Journal:  Ann Intern Med       Date:  2003-07-15       Impact factor: 25.391

10.  Effects of labelling on income, work and social function among hypertensive employees.

Authors:  M E Johnston; E S Gibson; C W Terry; R B Haynes; D W Taylor; A Gafni; J I Sicurella; D L Sackett
Journal:  J Chronic Dis       Date:  1984
  10 in total
  8 in total

1.  Dipstick proteinuria as a screening strategy to identify rapid renal decline.

Authors:  William F Clark; Jennifer J Macnab; Jessica M Sontrop; Arsh K Jain; Louise Moist; Marina Salvadori; Rita Suri; Amit X Garg
Journal:  J Am Soc Nephrol       Date:  2011-08-01       Impact factor: 10.121

2.  Chronic kidney disease in patients with diabetes mellitus type 2 or hypertension in general practice.

Authors:  Victor van der Meer; H Petra M Wielders; Diana C Grootendorst; Joost S de Kanter; Yvo Wj Sijpkens; Willem Jj Assendelft; Jacobijn Gussekloo; Friedo W Dekker; Ymte Groeneveld
Journal:  Br J Gen Pract       Date:  2010-12       Impact factor: 5.386

3.  The costs and benefits of automatic estimated glomerular filtration rate reporting.

Authors:  Julia R den Hartog; Peter P Reese; Borut Cizman; Harold I Feldman
Journal:  Clin J Am Soc Nephrol       Date:  2009-01-28       Impact factor: 8.237

4.  Screening for CKD with eGFR: doubts and dangers.

Authors:  Richard J Glassock; Christopher Winearls
Journal:  Clin J Am Soc Nephrol       Date:  2008-07-30       Impact factor: 8.237

5.  Screening for albuminuria identifies individuals at increased renal risk.

Authors:  Marije van der Velde; Nynke Halbesma; Frank T de Charro; Stephan J L Bakker; Dick de Zeeuw; Paul E de Jong; Ronald T Gansevoort
Journal:  J Am Soc Nephrol       Date:  2009-02-11       Impact factor: 10.121

6.  Screening for kidney disease in vascular patients: SCreening for Occult REnal Disease (SCORED) experience.

Authors:  Heejung Bang; Madhu Mazumdar; George Newman; Andrew S Bomback; Christie M Ballantyne; Allan S Jaffe; Phyllis A August; Abhijit V Kshirsagar
Journal:  Nephrol Dial Transplant       Date:  2009-03-26       Impact factor: 5.992

7.  Mild Albuminuria Is a Risk Factor for Faster GFR Decline in the Nondiabetic Population.

Authors:  Toralf Melsom; Marit Dahl Solbu; Jørgen Schei; Vidar Tor Nyborg Stefansson; Jon Viljar Norvik; Trond Geir Jenssen; Tom Wilsgaard; Bjørn Odvar Eriksen
Journal:  Kidney Int Rep       Date:  2018-02-08

8.  Immunosuppressants or corticosteroids compared with supportive therapy: a systematic review and meta-analysis on the efficacy and safety for IgA nephropathy treatment.

Authors:  Qipu Feng; Ying Xiong; Juexi Wang; Li Feng
Journal:  Ann Transl Med       Date:  2022-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.